The latest edition of the mhGAP guideline has been developed to assist countries in addressing the increasing challenges of mental, neurological and substance use (MNS) conditions. This new version includes 30 updated and 18 new recommendations, along with 90 existing ones, making it the third iteration of the guideline. The revised recommendations are designed to provide high-quality, timely, transparent, and evidence-based guidance to non-specialist health workers in low and middle-income countries for effectively treating and caring for individuals with MNS conditions. With a focus on narrowing the treatment gap, this guideline aims to improve capacity to address MNS conditions in growing need.
